Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Pharma Marketing Automation for Outcome Based Measurement
Pharma marketing automation replaces vanity metrics with real outcomes by tracking doctor engagement, prescription growth, and patient adherence.
|
Best Healthcare Marketing Agencies Transforming Pharma Growth
If you’re leading marketing for a pharma brand in India, you already know the challenge isn’t ideas it’s execution. The gap between what’s planned and what gets delivered keeps widening. Best…
|
Precision Health Campaigns Driving Smarter Pharma Growth
Pharma marketing is shifting from broad awareness to precision-driven communication. For years, brands relied on repetitive messaging and field promotions that treated every doctor or patient the…
|
Pharma Campaign Personalization Driving Better Outcomes
In pharma, great ideas often lose their edge by the time they reach the audience. Messages sound the same, visuals blur together, and public health efforts like hepatitis awareness end up competing…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
